Theranos claimed it could perform numerous medical tests using just a small amount of blood. However, the company exaggerated its capabilities and misled investors. In reality, Theranos' technology did not work as promised and was found to produce inaccurate results by regulators. Elizabeth Holmes and others were later charged with fraud for deceiving investors about Theranos' blood testing abilities.
Theranos claimed it could perform numerous medical tests using just a small amount of blood. However, the company exaggerated its capabilities and misled investors. In reality, Theranos' technology did not work as promised and was found to produce inaccurate results by regulators. Elizabeth Holmes and others were later charged with fraud for deceiving investors about Theranos' blood testing abilities.
Original Description:
slides on Growth story of Theranos and ground reality
Theranos claimed it could perform numerous medical tests using just a small amount of blood. However, the company exaggerated its capabilities and misled investors. In reality, Theranos' technology did not work as promised and was found to produce inaccurate results by regulators. Elizabeth Holmes and others were later charged with fraud for deceiving investors about Theranos' blood testing abilities.
Theranos claimed it could perform numerous medical tests using just a small amount of blood. However, the company exaggerated its capabilities and misled investors. In reality, Theranos' technology did not work as promised and was found to produce inaccurate results by regulators. Elizabeth Holmes and others were later charged with fraud for deceiving investors about Theranos' blood testing abilities.
Initially Holmes leveraged family connections to gain a foothold:
raised $6 million by the end of 2004. The promise and unique idea of conducting a multitude of tests over a pinch of blood attracted big investors. CEO Elizabeth Holmes featured on the covers of Fortune and TIME Partnerships with pharma companies such as Walgreens Booli INC, Pharmacy A etc. Theranos valued at $10 billion in 2015. Elizabeth Holmes: biggest self-made female billionaire. GROUND REALITY
Feb 2015: According to Stanford professor, Theranos had no peer-
reviewed research in medical literature. May 2015: University of Toronto professor Eleftherios Diamandis labelled Theranos’ research as exaggerated. Oct 2015: John Carreyrou of Wall Street Journal reported Theranos of using traditional blood-testing methods instead of The Edison device. Edison was reported of producing unsatisfactory results. The US FDA reports from 2014 and 2015 found major inaccuracies in testing of patients. GROUND REALITY (contd..) Even containers for blood collection were found to be not validated and were accused of not being approved prior to issuance. Aug 2016: “miniLaB” was introduced in American Association of Chemical Chemistry. Consequently, miniLaB was never able to perform the 200+ tests the company envisioned. Holmes took investors money over the virtual oath of zero interference from them. She also excluded investors from knowledge of any ongoing “research”. 2018: Elizabeth Holmes and Ramesh Balwani indicted by US SEC for fraud and deceiving investors. Also charged with marketing unrealiable and inaccurate blood testing methods.